IsoRay

IsoRay R&D per Employee

Delisted

The R&D Spending per Employee of IsoRay (ISR) as of Nov 4, 2026 is 15,840.49 USD. In the previous year, R&D Spending per Employee was 8,754.60 USD — a change of 80.94% (higher).

R&D per Employee

15,840.49USD

YoY

80.94%

Last updated:

R&D Spending per Employee of IsoRay is 2022 15,840.49 USD. R&D Spending per Employee of IsoRay was 2021 8,754.60 USD. It decreases by 80.94% higher compared to the previous year.

The IsoRay R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2015
3,771.60 USD
Jan 1, 2016
3,239.56 USD
Jan 1, 2017
5,920.25 USD
Jan 1, 2018
10,711.66 USD
Jan 1, 2019
9,042.94 USD
Jan 1, 2020
6,907.98 USD
Jan 1, 2021
8,754.60 USD
Jan 1, 2022
15,840.49 USD
The IsoRay R&D per Employee history
YEARR&D per EmployeeYoY
15,840.49USD+80.94%
8,754.60USD+26.73%
6,907.98USD-23.61%
9,042.94USD-15.58%
10,711.66USD+80.93%
5,920.25USD+82.75%
3,239.56USD-14.11%
3,771.60USD-8.08%
4,103.09USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

IsoRay Stock analysis

What does IsoRay do? The company IsoRay Inc is a leading global company in the field of brachytherapy and specializes in the development of novel medical devices for the treatment of cancer. The company's history dates back to the 1980s when it was founded by a team of doctors and scientists. IsoRay Inc's business model is based on the research, development, and manufacturing of medical products used in the treatment of cancer. Brachytherapy is a particularly important focus. This involves a treatment method where radioactive seeds or sources are directly implanted into the tumor. The radiation destroys the cancer cells without damaging the surrounding tissue. IsoRay Inc's product range includes a variety of medical devices and accessories for conducting brachytherapy procedures. The company specializes in the development of high-tech products that enable precise and effective radiation therapy. This includes, for example, radioactive seeds that are directly implanted into the tumor or apparatuses that can selectively use radiation in specific structures of the body. A special focus of IsoRay Inc is computer-assisted planning of brachytherapy treatments. The tumor is precisely measured and the radiation sources are individually customized based on the data to achieve an optimal radiation dose. This planning is done using modern software and is an important factor for the successful treatment of cancer. In addition to research and development of medical products, IsoRay Inc also encompasses the production and distribution of these products. The company operates in more than 30 countries worldwide and collaborates closely with numerous clinics and practices to research and improve new technologies in the field of radiation therapy. One of IsoRay Inc's most well-known products is the "Cesium-131 Brachytherapy seed." This radioactive seed is particularly small and therefore ideal for targeted radiation therapy of tumors. It is used in almost all clinical areas worldwide and is considered particularly safe and effective. Other products of the company include the "Gladius™ Applicator Needle," a device for precise placement of radiation sources in tumors, as well as "Intraoperative Application Systems" that enable effective radiation therapy during surgery. Overall, IsoRay Inc is considered an innovative and successful company in the field of brachytherapy and radiation therapy. The constant development and improvement of its own products is a key factor for the company's success. High quality and close collaboration with research and practice are central to its operations. IsoRay is one of the most popular companies on Eulerpool.

Frequently Asked Questions about IsoRay stock

R&D Spending per Employee of IsoRay is 15,840.49 USD in 2022.

R&D Spending per Employee of IsoRay changed from 8,754.60 USD to 15,840.49 USD, representing a 80.94% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee IsoRay since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's IsoRay historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — IsoRay

All Key Metrics — IsoRay